Estrogen ineffective in treating urinary incontinence

Keyphrases

• Placebo 100%
• Estrogen 100%
• Urinary Incontinence 100%
• Treatment Group 100%
• Parabasal 100%
• Placebo Groups 100%
• Randomized Placebo-controlled Trial 50%
• Prospective Randomized Trial 50%
• Progesterone 50%
• Health-related Quality of Life 50%
• Condition-dependent 50%
• Urodynamic Study 50%
• Patient Report 50%
• Estradiol Level 50%
• Community-dwelling 50%
• Patient Satisfaction 50%
• Frequency Dependence 50%
• Cell Count 50%
• Stress Incontinence 50%
• Detrusor Instability 50%
• Plasma Estradiol 50%
• Conjugated Equine Estrogens 50%
• Micturition 50%
• Quality of Life Measurement 50%
• Vaginal Smears 50%
• Am(III) 50%
• Fluid Loss 50%
• Estrogenic Response 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Placebo 100%
• Urine Incontinence 100%
• Diethylstilbestrol 40%
• Conjugated Estrogen 20%
• Dehydration 20%
• Detrusor Dyssynergia 20%
• Progesterone 20%
• Ethinylestradiol 20%
• Stress Incontinence 20%